Ausgabe 1/2013
Inhalt (17 Artikel)
MEG3: a novel long noncoding potentially tumour-suppressing RNA in meningiomas
Vladimir Balik, Josef Srovnal, Igor Sulla, Ondrej Kalita, Tatiana Foltanova, Miroslav Vaverka, Lumir Hrabalek, Marian Hajduch
Radiation induced brain injury: assessment of white matter tracts in a pre-clinical animal model using diffusion tensor MR imaging
Silun Wang, Deqiang Qiu, Kwok-Fai So, Ed X. Wu, Lucullus H. T. Leung, Jing Gu, Pek-Lan Khong
ZFX regulates glioma cell proliferation and survival in vitro and in vivo
Zhichuan Zhu, Kui Li, Dafeng Xu, Yongjie Liu, Hailiang Tang, Qing Xie, Liqian Xie, Jiwei Liu, Hongtao Wang, Ye Gong, Zelan Hu, Jing Zheng
miRNA-mediated tumor specific delivery of TRAIL reduced glioma growth
Yongli Bo, Guocai Guo, Weicheng Yao
Harmine hydrochloride inhibits Akt phosphorylation and depletes the pool of cancer stem-like cells of glioblastoma
Huailei Liu, Dayong Han, Yaohua Liu, Xu Hou, Jianing Wu, Huadong Li, Jie Yang, Chen Shen, Guang Yang, Changyu Fu, Xianfeng Li, Hui Che, Jing Ai, Shiguang Zhao
EGF signalling and rapamycin-mediated mTOR inhibition in glioblastoma multiforme evaluated by phospho-specific flow cytometry
Isabelle Cornez, Mrinal Joel, Kjetil Taskén, Iver A. Langmoen, Joel C. Glover, Torunn Berge
MicroRNA-107 inhibits glioma cell migration and invasion by modulating Notch2 expression
Lei Chen, Xiang-Rong Chen, Run Zhang, Peng Li, Yi Liu, Ke Yan, Xiao-Dan Jiang
H3.3 G34R mutations in pediatric primitive neuroectodermal tumors of central nervous system (CNS-PNET) and pediatric glioblastomas: possible diagnostic and therapeutic implications?
Marco Gessi, Gerrit H. Gielen, Jennifer Hammes, Evelyn Dörner, Anja zur Mühlen, Andreas Waha, Torsten Pietsch
Knockdown of RLIP76 expression by RNA interference inhibits invasion, induces cell cycle arrest, and increases chemosensitivity to the anticancer drug temozolomide in glioma cells
Qi Wang, Jun Qian, JunYu Wang, Chun Luo, Juxiang Chen, Guohan Hu, Yicheng Lu
Temozolomide use in adult patients with gliosarcoma: an evolving clinical practice
Gary V. Walker, Mark R. Gilbert, Sujit S. Prabhu, Paul D. Brown, Mary Frances McAleer
The incidence and significance of multiple lesions in glioblastoma
Reena P. Thomas, Linda W. Xu, Robert M. Lober, Gordon Li, Seema Nagpal
Disability, body image and sports/physical activity in adult survivors of childhood CNS tumors: population-based outcomes from a cohort study
Krister K. Boman, Lina Hörnquist, Lisanne De Graaff, Jenny Rickardsson, Birgitta Lannering, Göran Gustafsson
A very rare cancer in Down syndrome: medulloblastoma. Epidemiological data from 13 countries
Daniel Satgé, Charles A. Stiller, Stefan Rutkowski, André O. von Bueren, Brigitte Lacour, Danièle Sommelet, Motoi Nishi, Maura Massimino, Maria Luisa Garré, Florencia Moreno, Henrik Hasle, Zsuzsanna Jakab, Mark Greenberg, Nicolas von der Weid, Claudia Kuehni, Oscar Zurriaga, Maria-Luisa Vicente, Rafael Peris-Bonet, Martin Benesch, Michel Vekemans, Sheena G. Sullivan, Christian Rickert
Delayed development of a rhabdomyosarcoma following radiation for a spinal cord glioma
Edmond Mazbani, Robin L. Jones, James Fink, Marc C. Chamberlain
Erratum to: Delayed development of a rhabdomyosarcoma following radiation for a spinal cord glioma
Edmond Marzbani, Robin L. Jones, James Fink, Marc C. Chamberlain
Tryptophan PET in pretreatment delineation of newly-diagnosed gliomas: MRI and histopathologic correlates
David O. Kamson, Csaba Juhász, Amy Buth, William J. Kupsky, Geoffrey R. Barger, Pulak K. Chakraborty, Otto Muzik, Sandeep Mittal
Re-irradiation with and without bevacizumab as salvage therapy for recurrent or progressive high-grade gliomas
Thomas Hundsberger, Detlef Brügge, Paul M. Putora, Patrik Weder, Johannes Weber, Ludwig Plasswilm